首页> 外文期刊>BJU international >Development of a cell-isolation method for human prostatic smooth muscle cells based on cell type-specific activation of the SM22 gene promoter.
【24h】

Development of a cell-isolation method for human prostatic smooth muscle cells based on cell type-specific activation of the SM22 gene promoter.

机译:基于SM22基因启动子的细胞类型特异性激活,用于人类前列腺平滑肌细胞的细胞分离方法的开发。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To separate smooth muscle cells (SMCs) from fibroblasts in cultured human prostatic stromal cells (PrSCs) by characterizing the SM22 promoter as a prostatic SMC-specific gene promoter, and to investigate its use for a promoter-based cell-sorting method, as SMCs are critical for stromal function and the pathological changes in the development of benign prostatic hyperplasia. MATERIALS AND METHODS: Human PrSCs were cultured in SMC-selective medium or standard medium, respectively, to obtain typical cultures of SMCs and fibroblasts. SM22 promoter activity and specificity were analysed by luciferase reporter-gene assay. A dual-colour vector was constructed with the expression of the red fluorescent protein (RFP) under the control of the 1.4 kb SMC-specific SM22 promoter, and the expression of the green fluorescent protein (GFP) under cytomegalovirus promoter. Fluorescence-activated cell sorting (FACS) was used to isolate and enrich GFP+/RFP+ and GFP+/RFP- cells. Cell phenotype was confirmed by reverse transcription-polymerase chain reaction and immunofluorescence. RESULTS: The 1.4 kb SM22 promoter activity was much higher in PrSCs cultured in SMC-selective medium. Immunofluorescence staining and merged fluorescence microscopy ensured that SM22 promoter-driven GFP positive cells were SMCs. After transfection of the dual-colour vector into PrSCs, GFP+/RFP+ cells (SMCs) and GFP+/RFP- cells (fibroblasts) were isolated by FACS. The phenotype of FACS-enriched SMCs and fibroblasts was confirmed. CONCLUSION: These results indicate that the 1.4 kb SM22 promoter is specific for prostatic SMCs. This dual-colour vector could be a useful tool for separating living SMCs from fibroblasts using FACS.
机译:目的:通过将SM22启动子表征为前列腺SMC特异性基因启动子,以从培养的人前列腺基质细胞(PrSCs)中从成纤维细胞中分离出平滑肌细胞(SMC),并研究其在基于启动子的细胞分选方法中的用途,因为SMC对于基质功能和良性前列腺增生发展中的病理变化至关重要。材料与方法:将人PrSCs分别在SMC选择性培养基或标准培养基中培养,以获得SMCs和成纤维细胞的典型培养物。 SM22启动子的活性和特异性通过萤光素酶报告基因检测。构建了双色载体,其在1.4 kb SMC特异性SM22启动子的控制下表达红色荧光蛋白(RFP),在巨细胞病毒启动子下表达绿色荧光蛋白(GFP)。荧光激活细胞分选术(FACS)用于分离和富集GFP + / RFP +和GFP + / RFP-细胞。通过逆转录-聚合酶链反应和免疫荧光证实细胞表型。结果:在SMC选择性培养基中培养的PrSCs中1.4kb SM22启动子活性高得多。免疫荧光染色和融合荧光显微镜检查确保SM22启动子驱动的GFP阳性细胞为SMC。将双色载体转染到PrSC中后,通过FACS分离GFP + / RFP +细胞(SMC)和GFP + / RFP-细胞(成纤维细胞)。证实了富含FACS的SMC和成纤维细胞的表型。结论:这些结果表明1.4 kb SM22启动子对前列腺SMC具有特异性。这种双色载体可能是使用流式细胞仪从活细胞中分离活体SMC的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号